Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus

NCT00241085 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 392

Last updated 2011-11-08

No results posted yet for this study

Summary

This is a study of whether valsartan affects levels of proteinuria in patients with type 2 diabetes and hypertension.

Conditions

Interventions

DRUG

valsartan

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-11-30
Primary Completion
2005-08-31
Completion
2005-08-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00241085 on ClinicalTrials.gov